Your session is about to expire
← Back to Search
PU-H71 for Lymphoma
Study Summary
This trial is testing a new drug, called PU-H71, to find out what effects it has on patients and cancer cells. PU-H71 blocks a protein called Heat Shock Protein-90 (Hsp90). Hsp90 is found in both normal and cancer cells, but may be more important in cancer cells. Attacking Hsp90 can stop the function of certain proteins that are needed for cancer cells to survive.
- Myeloproliferative Neoplasms
- Metastatic Tumor
- Lymphoma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does PU-H71 pose any potential risks to patients?
"Our team at Power evaluated PU-H71's safety and assigned it a score of 1 due to the paucity of evidence from Phase 1 trials that support its efficacy or security."
Are there any related studies to PU-H71 that have already been conducted?
"Presently, there are 2 active trials for PU-H71; neither of which is in Phase 3. Both studies are situated in the city of New york and require patients to enroll at participating sites."
What is the aggregate enrollment for this trial?
"Presently, this particular trial is not enrolling patients. The original announcement was made on July 1st 2011 and the most recent update occurred June 8th 2022. If you are seeking out other studies related to lymphoma, there are currently 3999 clinical trials actively recruiting participants as well as 2 specific to PU-H71."
Are there vacancies available for individuals interested in participating in this research?
"Sadly, this medical trial is no longer taking on participants. It was first posted in July 2011 and its most recent update occurred on June 8th 2022. However, if you are looking for other studies to join there are 3999 trials involving lymphoma and two PU-H71 clinical studies actively recruiting volunteers."
Share this study with friends
Copy Link
Messenger